HealthStream, Inc. (NASDAQ:HSTM) Receives Consensus Rating of “Hold” from Brokerages

HealthStream, Inc. (NASDAQ:HSTM) has been assigned a consensus recommendation of “Hold” from the five brokerages that are covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $25.00.

A number of analysts have recently weighed in on the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of HealthStream in a research note on Wednesday, October 8th. Canaccord Genuity Group set a $25.00 price target on shares of HealthStream in a report on Thursday, January 8th. Citigroup reiterated a “market perform” rating on shares of HealthStream in a research note on Tuesday, January 6th. Finally, Wall Street Zen cut HealthStream from a “buy” rating to a “hold” rating in a report on Saturday, November 22nd.

Insiders Place Their Bets

In related news, CTO Jeff Cunningham sold 2,100 shares of the stock in a transaction on Wednesday, December 10th. The shares were sold at an average price of $24.09, for a total transaction of $50,589.00. Following the sale, the chief technology officer directly owned 31,489 shares of the company’s stock, valued at approximately $758,570.01. This represents a 6.25% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Kevin P. O’hara sold 2,000 shares of the firm’s stock in a transaction on Monday, December 8th. The shares were sold at an average price of $24.26, for a total transaction of $48,520.00. Following the sale, the executive vice president owned 16,373 shares in the company, valued at approximately $397,208.98. This represents a 10.89% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 5,680 shares of company stock worth $139,336. Corporate insiders own 20.50% of the company’s stock.

Institutional Investors Weigh In On HealthStream

Several hedge funds have recently modified their holdings of HSTM. Copeland Capital Management LLC increased its stake in shares of HealthStream by 6.2% in the 4th quarter. Copeland Capital Management LLC now owns 887,553 shares of the technology company’s stock valued at $20,476,000 after purchasing an additional 51,470 shares in the last quarter. Geode Capital Management LLC grew its holdings in HealthStream by 5.3% in the second quarter. Geode Capital Management LLC now owns 766,193 shares of the technology company’s stock valued at $21,202,000 after purchasing an additional 38,868 shares during the period. Acadian Asset Management LLC grew its holdings in HealthStream by 5.1% in the second quarter. Acadian Asset Management LLC now owns 762,343 shares of the technology company’s stock valued at $21,077,000 after purchasing an additional 37,004 shares during the period. JPMorgan Chase & Co. increased its position in shares of HealthStream by 74.6% in the third quarter. JPMorgan Chase & Co. now owns 432,822 shares of the technology company’s stock valued at $12,223,000 after buying an additional 184,917 shares in the last quarter. Finally, First Eagle Investment Management LLC raised its stake in shares of HealthStream by 1.1% during the 4th quarter. First Eagle Investment Management LLC now owns 413,698 shares of the technology company’s stock worth $9,544,000 after buying an additional 4,300 shares during the period. 69.58% of the stock is owned by hedge funds and other institutional investors.

HealthStream Price Performance

NASDAQ HSTM opened at $20.40 on Friday. HealthStream has a 1 year low of $20.39 and a 1 year high of $34.24. The company has a market cap of $605.27 million, a price-to-earnings ratio of 30.00, a PEG ratio of 2.26 and a beta of 0.44. The stock’s fifty day moving average price is $23.08 and its 200 day moving average price is $25.47.

HealthStream (NASDAQ:HSTM) last released its earnings results on Monday, November 3rd. The technology company reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.03. HealthStream had a return on equity of 5.82% and a net margin of 6.93%.The firm had revenue of $76.47 million during the quarter, compared to the consensus estimate of $75.52 million. Research analysts expect that HealthStream will post 0.63 earnings per share for the current year.

HealthStream declared that its Board of Directors has initiated a share buyback plan on Tuesday, November 11th that authorizes the company to repurchase $10.00 million in shares. This repurchase authorization authorizes the technology company to purchase up to 1.3% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s management believes its stock is undervalued.

HealthStream Company Profile

HealthStream, Inc is a Nashville, Tennessee–based provider of workforce development and learning management solutions for healthcare organizations. Since its founding in 1990, the company has focused on helping hospitals, clinics and other care providers streamline staff training, ensure regulatory compliance and monitor employee performance. HealthStream’s platform integrates online courses, skill competency assessments and credential management tools to support workforce readiness across the healthcare continuum.

The company’s core offerings include a learning management system (LMS) designed specifically for clinical and nonclinical personnel, a competency management suite that tracks skill acquisition and validation, and a content library featuring evidence-based clinical and compliance training modules.